(19)
(11) EP 4 740 023 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24747978.5

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
G16H 10/20(2018.01)
G16H 50/70(2018.01)
 G16H 10/40(2018.01)
G16H 50/20(2018.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/6893; G01N 2800/085; G01N 2333/70596; G16H 10/40; G16H 10/20; G16H 50/70; G16H 50/20
(86) International application number:
PCT/EP2024/068737
(87) International publication number:
WO 2025/008404 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 04.07.2023 EP 23183382

(71) Applicant: Universität Regensburg, in Vertretung des Freistaats Bayern
93053 Regensburg (DE)

(72) Inventors:
  • WERNER, Jens M.
    93053 Regensburg (DE)
  • BITTERER, Florian
    93133 Burglengenfeld (DE)
  • HUTCHINSON, James Alexander
    93051 Regensburg (DE)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)

   


(54) USE OF SOLUBLE CD46 CONCENTRATION FROM PERIPHERAL BLOOD AS A PARAMETER FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE